Open Insider Trading Activity for Monopar Therapeutics Chief Executive Officer Robinson Chandler
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction MNPR | 2026-09-28 | 2026-09-24 | Monopar Therapeutics | Robinson Chandler | Chief Executive Officer | Sell | 4 | 29,056 | $88.00 | $2,556,850.94 | 22.64% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. MNPR | 2019-12-20 | 2019-12-18 | Monopar Therapeutics | Robinson Chandler | Director,Officer,TenPercentOwner | Buy | 1 | 125,000 | $8.00 | $1,000,000.00 | 42.86% | View Filing |